JP2003510270A5 - - Google Patents

Download PDF

Info

Publication number
JP2003510270A5
JP2003510270A5 JP2001526159A JP2001526159A JP2003510270A5 JP 2003510270 A5 JP2003510270 A5 JP 2003510270A5 JP 2001526159 A JP2001526159 A JP 2001526159A JP 2001526159 A JP2001526159 A JP 2001526159A JP 2003510270 A5 JP2003510270 A5 JP 2003510270A5
Authority
JP
Japan
Prior art keywords
active agent
region
active
substance
carrier layer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001526159A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003510270A (ja
Filing date
Publication date
Priority claimed from DE19946822A external-priority patent/DE19946822A1/de
Application filed filed Critical
Publication of JP2003510270A publication Critical patent/JP2003510270A/ja
Publication of JP2003510270A5 publication Critical patent/JP2003510270A5/ja
Pending legal-status Critical Current

Links

JP2001526159A 1999-09-30 2000-09-16 活性および／または補助物質を含み、該物質を制御放出する製剤、ならびに、その使用および製造 Pending JP2003510270A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19946822.2 1999-09-30
DE19946822A DE19946822A1 (de) 1999-09-30 1999-09-30 Wirk- und/oder Hilfsstoffe enthaltende Zubereitung mit steuerbarer Freisetzung dieser Stoffe, sowie ihre Verwendung und Herstellung
PCT/EP2000/009061 WO2001022947A2 (de) 1999-09-30 2000-09-16 Wirk- und/oder hilfsstoffe enthaltende zubereitung mit steuerbarer freisetzung dieser stoffe, sowie ihre verwendung und herstellung

Publications (2)

Publication Number Publication Date
JP2003510270A JP2003510270A (ja) 2003-03-18
JP2003510270A5 true JP2003510270A5 (enExample) 2010-12-09

Family

ID=7923805

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001526159A Pending JP2003510270A (ja) 1999-09-30 2000-09-16 活性および／または補助物質を含み、該物質を制御放出する製剤、ならびに、その使用および製造

Country Status (19)

Country Link
US (1) US20080241216A1 (enExample)
EP (1) EP1216035B1 (enExample)
JP (1) JP2003510270A (enExample)
KR (1) KR100666901B1 (enExample)
CN (1) CN1232245C (enExample)
AR (1) AR025914A1 (enExample)
AT (1) ATE317258T1 (enExample)
AU (1) AU777621B2 (enExample)
BR (1) BR0014647A (enExample)
CA (1) CA2387710C (enExample)
CY (1) CY1106080T1 (enExample)
DE (2) DE19946822A1 (enExample)
DK (1) DK1216035T3 (enExample)
ES (1) ES2258019T3 (enExample)
IL (1) IL148907A (enExample)
MX (1) MXPA02003252A (enExample)
PT (1) PT1216035E (enExample)
TW (1) TWI255724B (enExample)
WO (1) WO2001022947A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2839645B1 (fr) * 2002-05-15 2005-08-05 Backert Marie Elisabeth Cuine Systeme multilamellaire pour l'administration de substances actives (en particulier des medicaments) par ingestion par la voie orale
EP1920768A1 (en) * 2006-11-10 2008-05-14 Abbott GmbH & Co. KG Solid dosage form with a film containing an active substance, as well as its method of production
EP2701668A1 (en) * 2011-04-29 2014-03-05 Massachusetts Institute of Technology Layer processing for pharmaceuticals
US10213960B2 (en) 2014-05-20 2019-02-26 Massachusetts Institute Of Technology Plasticity induced bonding
US9808608B2 (en) * 2014-11-16 2017-11-07 International Business Machines Corporation Helical coil delivery device for active agent
JP7710850B2 (ja) 2017-12-29 2025-07-22 ラクソン メディカル アーゲー 薬物送達システム
KR102718551B1 (ko) 2017-12-29 2024-10-17 락손 메디칼 아게 약물 전달 시스템을 제조하기 위한 방법
EP4125806B1 (en) * 2020-03-31 2024-10-16 Danmarks Tekniske Universitet A flexible foil for the delivery of therapeutic cargos
DE102021106491A1 (de) 2021-03-17 2022-09-22 Lts Lohmann Therapie-Systeme Ag. Gerollte oral thin films mit hoher wirkstoffbeladung

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3625214A (en) * 1970-05-18 1971-12-07 Alza Corp Drug-delivery device
CH624846A5 (en) * 1975-12-15 1981-08-31 Hoffmann La Roche Solid pharmaceutical unit dose form and process and apparatus for producing it
AU528190B2 (en) * 1978-11-07 1983-04-21 Pfizer Inc. Device for oral administration of drugs to ruminant animals
US4291015A (en) * 1979-08-14 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing a vasodilator
US4601893A (en) * 1984-02-08 1986-07-22 Pfizer Inc. Laminate device for controlled and prolonged release of substances to an ambient environment and method of use
US4767627A (en) * 1985-05-29 1988-08-30 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
AU7568394A (en) * 1993-08-19 1995-03-14 Cygnus Therapeutic Systems Water-soluble pressure-sensitive mucoadhesive and devices provided therewith for emplacement in a mucosa-lined body cavity
DE19715794C1 (de) * 1997-04-16 1998-12-03 Roehm Gmbh Laminare Arzneiform und Verfahren zu ihrer Herstellung

Similar Documents

Publication Publication Date Title
JP2003512395A5 (enExample)
DE69942921D1 (de) Osmotische Dosierungsform mit verlängerter Wirkstoffabgabe
IT1283102B1 (it) Composizione terapeutica per la somministrazione transdermica di un principio attivo estrogeno o progestinico o di loro miscele
ES2195308T3 (es) Composicon farmaceutica de fenofibrato que presenta una biodisponibilidad elevada, y metodo para su preparacion.
JP2002536387A5 (enExample)
PT1183014E (pt) Composicoes farmaceuticas orais de libertacao controlada e de dissimulacao de sabor
DE69819481D1 (de) Formulierungen von clarithromycin mit verlängerter wirkstoff-freisetzung
HUP0200442A3 (en) Azeotrope-like composition comprising 1,1,1,3,3-pentafluorobutane and its use
IL149573A0 (en) Multi-layer preparation in film form, consisting of hydrophilic polymers, for the rapid release of active ingredients
NO20024919L (no) Hydrofil/lipofil polymer matriksdoseringsformulering
FI19991852L (fi) Uusi monikerroksinen materiaali, joka käsittää vaikuttavan ainesosan, ja sen valmistus
ID26340A (id) Kapsul ganda dengan penggunaan bahan-bahan aktif dalam berbagai macam pengobatan
JP2002532112A5 (enExample)
TR200100931T2 (tr) Yeni sürekli salınımlı oral formülasyonlar
FI973452L (fi) Nauhoitettu annosmuoto aktiivisen aineen pidennettyyn jakamiseen
CA2316277A1 (en) Tablet for instant and prolonged release of one or more active substances
EE04965B1 (et) Imidasoimidasoolid ja triasoolid kui p?letikuvastased hendid, nende kasutamine ravimite valmistamiseks ning farmatseutiline kompositsioon
NZ288144A (en) Active agent sustained release capsule: fluid expandable layers and active agent layers
FI980822A0 (fi) Farmaseuttinen koostumus vaikuttavan aineen iho- tai limakalvopintaan tai iho- tai limakalvopinnan läpi
AU6872201A (en) Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
JP2003510270A5 (enExample)
MX9202407A (es) Composicion farmaceutica que contiene un compuesto de alilamina como el agente activo y proceso para su preparacion.
FR2732967B1 (fr) 1-phenylpyrazole-3-carboxamides substitues, actifs sur la neurotensine, leur preparation, les compositions pharmaceutiques en contenant
EE200000595A (et) Toimeaine viimine kandjamaatriksisse
DE60015059D1 (de) Zusammensetzung zur kontrollierten Wirkstoffabgabe enthaltend eine verzögert feisetzende Schicht und eine schnell freisetzende Schicht